News | October 09, 2023
Thermo Fisher Scientific expands St. Louis manufacturing for complex biologic treatments
Increased capability to produce medicines for challenging diseases including cancer
Increased capability to produce medicines for challenging diseases including cancer
Adding 20,000 liters of installed biologics drug substance manufacturing capacity
Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes
The integrated capabilities at Unit 2 offer significant operational flexibility, greater efficiency, and varied scope within the same premise
Bora establishes a leadership position in Taiwan's CDMO sector as it continues to expand into the global CDMO market
Company has invested $150 million to build a 150,000 square-foot commercial manufacturing facility in Research Triangle Park (RTP), North Carolina
Bionova Scientific’s process development capabilities are particularly highly regarded in the industry, and it has a rich track record regarding complex next-generation antibody drugs, which are typically challenging to manufacture
Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation
MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies
The partnership demonstrates increasing adoption of tetra data to create unrestricted innovation
Subscribe To Our Newsletter & Stay Updated
